The study delineates the clinical spectrum of PURA syndrome and finds no significant genotype-phenotype correlation regarding disease severity.
Answers are grounded in this paper and cite their sources.
Caution against using mutation class for prognosis in PURA syndrome; leaves open identification of modifiers in larger cohorts.
We delineate the clinical spectrum of PURA syndrome with the identification of 32 additional individuals. The identification of one individual through targeted Sanger sequencing points towards the clinical recognisability of the syndrome. Genotype-phenotype analysis showed no significant correlation between mutation classes and disease severity.
No takes yet. Share an insight, caveat, or question.
Reijnders et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: